Effects of nintedanib by inclusion criteria for progression of interstitial lung disease

Maher, Toby M.; Brown, Kevin K.; Kreuter, Michael; Devaraj, Anand; Walsh, Simon L. F.; Lancaster, Lisa H.; Belloli, Elizabeth A.; Padilla, Maria; Behr, Juergen; Goeldner, Rainer-Georg; Tetzlaff, Kay; Schlenker-Herceg, Rozsa; Flaherty, Kevin R.

dc.contributor.author	Tetzlaff, Kay
dc.date.accessioned	2023-04-27T10:34:09Z
dc.date.available	2023-04-27T10:34:09Z
dc.date.issued	2022
dc.identifier.issn	0903-1936
dc.identifier.uri	http://hdl.handle.net/10900/139792
dc.language.iso	en	de_DE
dc.publisher	European Respiratory Soc Journals Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1183/13993003.04587-2020	de_DE
dc.subject.ddc	610	de_DE
dc.title	Effects of nintedanib by inclusion criteria for progression of interstitial lung disease	de_DE
dc.type	Article	de_DE
utue.quellen.id	20220728000000_02199
utue.personen.roh	Maher, Toby M.
utue.personen.roh	Brown, Kevin K.
utue.personen.roh	Kreuter, Michael
utue.personen.roh	Devaraj, Anand
utue.personen.roh	Walsh, Simon L. F.
utue.personen.roh	Lancaster, Lisa H.
utue.personen.roh	Belloli, Elizabeth A.
utue.personen.roh	Padilla, Maria
utue.personen.roh	Behr, Juergen
utue.personen.roh	Goeldner, Rainer-Georg
utue.personen.roh	Tetzlaff, Kay
utue.personen.roh	Schlenker-Herceg, Rozsa
utue.personen.roh	Flaherty, Kevin R.
dcterms.isPartOf.ZSTitelID	European Respiratory Journal	de_DE
dcterms.isPartOf.ZS-Issue	Article 2004587	de_DE
dcterms.isPartOf.ZS-Volume	59 (2)	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE